Join CSO John Skidmore at SciBarHealth Alzheimer’s Evening

Join us on 12 September for an evening of talks and discussion on Alzheimer’s disease, hosted by SciBarHealth and marking world Alzheimer’s month. Prof Giovanna Mallucci will speak about her group’s recent discovery of licensed drugs targeting processes that kill brain cells that are ready for clinical trials in dementia. Dr John Skidmore, Chief Scientific […]

Read more

The hunt for dementia treatments

As part of the Cambridge Science Festival, the Cambridge Drug Discovery Institute is opening its doors to the public.

Read more

New industry collaboration for Prof Rubinsztein

PhoreMost Ltd, a UK biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, has entered into a research collaboration with the laboratory of Prof David Rubinsztein at the University of Cambridge. Prof Rubinsztein’s lab focuses on understanding how autophagy, a cellular waste disposal system, could be manipulated to clear toxic protein build-up occurring in neurodegenerative diseases […]

Read more

Dementia: Catching the memory thief

It has been over a hundred years since Alzheimer’s disease was first described, and in that time we have learned much about the condition, but how close are we to having effective treatments and could one day we prevent dementia from even occurring? Released on World Alzheimer’s Day, September 21, a short film by the […]

Read more

Alzheimer’s Research UK launches three Drug Discovery Institutes

Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30m Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and UCL (University College London). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments […]

Read more

Showing 1-5 of 5 News